New Alliance Capital

Portfolio Co Investors 2026 for New Alliance Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

New Alliance Capital accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.3B. The median disclosed raise is $100M, and the largest is MediTrust Health at $463M, ahead of SPH Health Commerce ($426M) and GenScript ProBio ($240M).

The names that recur most often on these co-invested cap tables are New Alliance Capital (8 companies), Lilly Asia Ventures (2 companies), Legend Capital (2 companies), HSBC (1 company), Boyu Capital (1 company), Ant Group (1 company). By latest disclosed round, the market skews Series C (3), IPO (1), Series B (1), Series D (1).

Best funded New Alliance Capital companies

  1. MediTrust Health — $463M (latest: Series C)
  2. SPH Health Commerce — $426M (latest: Series C)
  3. GenScript ProBio — $240M (latest: Series C)
  4. InnoStar Semiconductor — $100M (latest: IPO)
  5. LYNK Pharmaceuticals — $50M (latest: Series B)
  6. Core Medical Technology — $29M (latest: Series D)
  7. Positive Sequence Biology — $6M (latest: Seed)
  8. Indiemicro — $3M

New Alliance Capital — related firms and companies (51)

New Alliance Capital alternatives · All research reports